Transcutaneous spinal cord stimulation (tSCS) has moved quickly from a research curiosity to a recognised tool in neurological rehabilitation. People living with spinal cord injury, stroke, and multiple sclerosis are asking us about it. Clinicians want to know which device to recommend. Equipment commissioners want evidence-led guidance before authorising spend that can run into tens of thousands of pounds per system.

A paper published in Nature Biomedical Engineering on 12 May 2026 has added something important to that conversation. It is not a clinical trial. It is a careful study of the physics and physiology that govern which nerve fibres a tSCS device actually recruits. The finding is consequential, and it bears directly on the choice of device.

In short: the waveform you choose determines whether tSCS does the thing rehabilitation needs it to do.

We have just recently redeveloped our sister site, fescycling.com, dedicated to functional electrical stimulation cycling: the evidence, the practicalities, and the questions that come up most often in clinic. The articles below are written for people considering FES cycling, the families and case managers supporting them, and clinicians who want a clearer view of what the technology can and cannot do.

If you are new to FES cycling, the first three are the natural starting point. The rest go deeper into specific questions, conditions, and day-to-day reality. Although our offered system is based on the Stim2Go unit from Pajunk, the articles should be of general interest to those who wish to learn more about FES cycling.

If you'd like more, there is a comprehensive online resource available at https://fescycling.com/guide and a AI powered chat to let you explore it.

Transcutaneous spinal cord stimulation (tSCS) represents a promising noninvasive neuromodulation technique for rehabilitation in spinal cord injury (SCI) and other neurological conditions.

From this article you will gain a clear understanding of how tSCS is used as a priming tool within rehabilitation, the research principles that guide its clinical application, how it is integrated alongside task-specific therapy, and what types of functional improvements and neuroplastic changes clinicians aim to achieve when it is delivered consistently over time.

I recently came across an interesting newsletter item from "Building the Elite" about the relative importance of training volume versus intensity.

The argument—made by someone preparing candidates for special forces selection—was that volume is the primary training variable to manage. This is because it has the greatest impact on the training programme's effectiveness, while intensity determines the type of adaptation you're targeting.

This struck me as highly relevant to neurological rehabilitation. Let's see if you agree.

Wondering how long it takes to notice benefits from FES cycling? This article breaks down what to expect in the first few sessions and over the following weeks, from early improvements in muscle activation and comfort to longer-term gains in strength, endurance, and performance. It explains why consistency matters, how individual factors can affect progress, and what milestones may indicate you’re on the right track. A helpful overview for anyone starting FES cycling and wanting a realistic timeline for results.

Choosing your first FES cycling system can feel overwhelming, especially with different features, set-ups, and clinical needs to consider. This practical guide breaks down the key things to look for, from ease of use and programming options to comfort, support, and long-term goals. Whether you’re exploring FES for rehabilitation, conditioning, or home use, this article helps you make a more informed decision and find a system that suits your needs and lifestyle.